Wall Street is positive on Paratek Pharmaceuticals Inc (PRTK). On average, analysts give PRTK a Strong Buy rating. The average price target is $15.333, which means analysts expect the stock to add by 474.27% over the next twelve months. That average ranking earns PRTK an Analyst Rating of 73, which is better than 73% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating PRTK a Strong Buy today. Find out what this means to you and get the rest of the rankings on PRTK!